Multiple Myeloma and Plasma Cell Neoplasm [clinicaltrials_resource:6d0e5b011d8f7abf61daea7602bed145]
Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002502]Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer [clinicaltrials:NCT00002504]Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma [clinicaltrials:NCT00002552]Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma [clinicaltrials:NCT00002599]High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse [clinicaltrials:NCT00002630]Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease [clinicaltrials:NCT00002652]Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma [clinicaltrials:NCT00002653]clinicaltrials:NCT00002657clinicaltrials:NCT00002678Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer [clinicaltrials:NCT00002742]High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis [clinicaltrials:NCT00002810]High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies [clinicaltrials:NCT00002818]Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma [clinicaltrials:NCT00002878]Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma [clinicaltrials:NCT00002907]Decitabine in Treating Patients With Melanoma or Other Advanced Cancer [clinicaltrials:NCT00002980]Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002989]Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma [clinicaltrials:NCT00003007]Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss [clinicaltrials:NCT00003077]Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003082]Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors [clinicaltrials:NCT00003107]clinicaltrials:NCT00003116Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003146]Interleukin-12 in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003149]Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation [clinicaltrials:NCT00003153]Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers [clinicaltrials:NCT00003163]Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003195]Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003270]Combination Chemotherapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003331]Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy [clinicaltrials:NCT00003341]High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis [clinicaltrials:NCT00003353]Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer [clinicaltrials:NCT00003395]Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003396]Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003398]Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003399]Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003401]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer [clinicaltrials:NCT00003406]Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer [clinicaltrials:NCT00003408]Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003451]Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003490]Combination Chemotherapy in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003493]
condition [clinicaltrials_vocabulary:condition]
Multiple Myeloma and Plasma Cell Neoplasm [clinicaltrials_resource:6d0e5b011d8f7abf61daea7602bed145]
Bio2RDF identifier
6d0e5b011d8f7abf61daea7602bed145
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6d0e5b011d8f7abf61daea7602bed145
identifier
clinicaltrials_resource:6d0e5b011d8f7abf61daea7602bed145
title
Multiple Myeloma and Plasma Cell Neoplasm
@en
label
Multiple Myeloma and Plasma Ce ...... e5b011d8f7abf61daea7602bed145]
@en